Haleon (NYSE:HLN) Stock Rating Lowered by Sanford C. Bernstein

Sanford C. Bernstein lowered shares of Haleon (NYSE:HLN - Free Report) from an outperform rating to a market perform rating in a research report sent to investors on Wednesday morning, MarketBeat Ratings reports.

Several other equities analysts have also recently weighed in on HLN. Morgan Stanley increased their price target on Haleon from $9.90 to $10.95 and gave the company an "overweight" rating in a report on Friday, September 20th. UBS Group raised Haleon to a "strong-buy" rating in a report on Tuesday, October 1st. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Haleon currently has a consensus rating of "Moderate Buy" and an average target price of $10.95.

Haleon Stock Up 0.4 %

HLN stock traded up $0.04 during midday trading on Wednesday, hitting $9.50. The company's stock had a trading volume of 11,082,673 shares, compared to its average volume of 7,514,995. The company has a market cap of $43.00 billion, a PE ratio of 27.94, a P/E/G ratio of 2.95 and a beta of 0.29. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The firm's 50-day moving average is $9.62 and its 200-day moving average is $9.67.

Hedge Funds Weigh In On Haleon

Institutional investors have recently bought and sold shares of the stock. Rhumbline Advisers boosted its position in shares of Haleon by 20.0% in the second quarter. Rhumbline Advisers now owns 48,966 shares of the company's stock worth $404,000 after purchasing an additional 8,160 shares during the period. Caprock Group LLC raised its holdings in Haleon by 21.9% during the second quarter. Caprock Group LLC now owns 53,410 shares of the company's stock valued at $441,000 after acquiring an additional 9,582 shares during the period. PFG Investments LLC lifted its position in shares of Haleon by 24.2% in the second quarter. PFG Investments LLC now owns 24,652 shares of the company's stock valued at $204,000 after acquiring an additional 4,811 shares in the last quarter. Wedbush Securities Inc. boosted its stake in shares of Haleon by 34.9% in the second quarter. Wedbush Securities Inc. now owns 92,366 shares of the company's stock worth $763,000 after acquiring an additional 23,886 shares during the period. Finally, Choreo LLC grew its position in shares of Haleon by 2,597.3% during the second quarter. Choreo LLC now owns 337,086 shares of the company's stock worth $2,804,000 after purchasing an additional 324,589 shares in the last quarter. 6.67% of the stock is owned by institutional investors.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.